Supplement AER Draft Guidance Omits Answers, But Recognizes Complexities
This article was originally published in The Tan Sheet
Executive Summary
FDA's draft guidance for dietary supplement adverse event reports encourages firms to employ health care professionals to take information from consumers and other sources of adverse event calls
You may also be interested in...
SBA Advocacy Office Joins Industry In Opposing AER Labeling Guidance
FDA should "better analyze the possible effects" its adverse event reporting draft guidance will have on the dietary supplement industry, according to the Small Business Administration's independent Office of Advocacy
SBA Advocacy Office Joins Industry In Opposing AER Labeling Guidance
FDA should "better analyze the possible effects" its adverse event reporting draft guidance will have on the dietary supplement industry, according to the Small Business Administration's independent Office of Advocacy
SBA Advocacy Office Joins Industry In Opposing AER Labeling Guidance
FDA should "better analyze the possible effects" its adverse event reporting draft guidance will have on the dietary supplement industry, according to the Small Business Administration's independent Office of Advocacy